title: Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
authors.forename: Shane L
authors.initials: SL
authors.lastname: Jackson
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Peterson
authors.forename: Luke R
authors.initials: LR
authors.lastname: Bereznicki
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D005240:Feasibility Studies; D006801:Humans; D010865:Pilot Projects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012107:Research Design; D013923:Thromboembolism / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin